Adaptation of Melodic Intonation Therapy to Spanish
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
This study was conducted in three phases: The first phase involved creation of a Spanish adaptation of the Melodic Intonation therapy; the second phase consisted of a pilot non-randomized intervention study to analyse its feasibility for use with 4 Spanish patients with poststroke nonfluent aphasia; the third phase consisted of a pilot randomised, crossover, intervention pilot trial in a different set of patients with poststroke nonfluent aphasia (N=20)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2010
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 8, 2018
CompletedFirst Posted
Study publicly available on registry
February 14, 2018
CompletedFebruary 14, 2018
February 1, 2018
6 years
February 8, 2018
February 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Communicative Activity Log questionnaire
6 weeks after the end of therapy
Boston Diagnostic Aphasia Examination
6 weeks after the end of therapy
Study Arms (2)
Melodic Intonation Therapy
ACTIVE COMPARATORThe duration of therapy was 12 sessions performed over a 6-week period. Each session lasted 30 minutes. They were performed individually by a speech-experienced therapist previously trained in Melodic Intonation Therapy.
Waiting list
NO INTERVENTIONNo intervention
Interventions
Eligibility Criteria
You may qualify if:
- Patients diagnosed with nonfluent aphasia due to unilateral stroke in the left hemisphere without neuroimaging evidence of lesions in the right hemisphere who fulfilled the following criteria:
- The time elapsed since the stroke exceeded 6 months.
- Patient had received a standard program of conventional speech therapy after stroke.
- Persistent nonfluent aphasia with the following characteristics:
- Severely restricted language, which might be limited to meaningless stereotypy; unlike that observed in verbal tasks, the patient might produce some real and relevant words when singing familiar songs.
- Poor repetition, even for single words.
- Moderately preserved language comprehension.
- The nonstereotyped language was produced with a slurring of speech.
- The total score for the repetition did not exceed the 70th percentile in the Boston Diagnostic Aphasia Examination. The score was obtained from the average score in three areas: repetition of words and repetition of phrases; listening comprehension exceeding the 15th percentile of Boston Diagnostic Aphasia Examination; and from the average score obtained in three areas: word comprehension, commands and complex ideational material.
- The patient was motivated, emotionally stable and had good attention.
- Signed informed consent was provided.
You may not qualify if:
- patients with a history of a previous stroke other than the index event or with any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that precluded appropriate follow-up in the study
- patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
- use of psychotropic drugs that interfere with patient evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A neuropsychologist blinded to the patients' clinical characteristics and the group to whom the patient was allocated evaluated outcome variables.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2018
First Posted
February 14, 2018
Study Start
February 1, 2010
Primary Completion
February 1, 2016
Study Completion
July 1, 2016
Last Updated
February 14, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share